Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04425239
Title Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer (IMPROVE)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute, Naples
Indications

colorectal cancer

Therapies

Fluorouracil + Irinotecan + Leucovorin + Panitumumab

Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST